Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
Clinical trial NCT04587687 · RECRUITING
Trial details
- NCT number
- NCT04587687
- Sponsor
- University of California, Davis
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-04
- Primary completion
- 2027-12-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.